Please login to the form below

Not currently logged in

Patients issued counterfeit guidance

A joint campaign from the RPSGB and the MHRA will see pharmacy patients issued with guidance on counterfeit drugs when they collect prescriptions

A joint campaign from the Royal Pharmaceutical Society of Great Britain (RPSGB) and the Medicines and Healthcare products Regulatory Agency (MHRA) will see pharmacy patients issued with guidance on counterfeit drugs when they collect prescriptions.

Patients will receive a double-sided postcard-sized leaflet containing information about counterfeit medicines, what to do if they suspect they have received counterfeit medicines and information on the safest way to purchase medicines.

The guidance also points out that all legitimate pharmacies operating online in Britain carry the Internet Pharmacy logo, which was launched by the RPSGB in January 2008.

The RPSGB's head of practice, Heidi Wright, said: "It's important that people are aware that they should always get their medicine from a reputable source such as a pharmacist or a registered online pharmacy site which has the RPSGB's Internet Pharmacy Logo – and I hope these postcards will help to achieve that."

The MHRA, the government agency responsible for ensuring the safety of medicines and medical devices, is also looking at ways to target those who deliberately use the internet to buy counterfeit medicine.

"The MHRA will not hesitate to take action against those who undermine public health. There is considerable risk to the public from obtaining medicines through unregulated websites," said Mick Deats, group manager of enforcement at the MHRA.

25th March 2009


Featured jobs

Subscribe to our email news alerts


Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...
Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....